𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Nephrogenic Systemic Fibrosis and Gadolinium-Based Contrast: What’s a Nephrologist to Do?

✍ Scribed by Mark A. Perazella

Book ID
109082853
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
75 KB
Volume
21
Category
Article
ISSN
0894-0959

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biochemical safety profiles of gadoliniu
Biochemical safety profiles of gadolinium-based extracellular contrast agents and nephrogenic systemic fibrosis
✍ Hale Ersoy; Frank J. Rybicki 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

## Abstract Gadolinium (Gd)‐based paramagnetic contrast agents are relatively safe when used in clinically recommended doses. However, with the rapidly expanding body of literature linking Gd‐based paramagnetic contrast agents and nephrogenic systemic fibrosis (NSF), awareness of the potential side

Gadolinium-based contrast agents and nep
Gadolinium-based contrast agents and nephrogenic systemic fibrosis: Why did it happen and what have we learned?
✍ Jeffrey C. Weinreb; Ali K. Abu-Alfa 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

## Abstract This article addresses two questions about gadolinium‐based contrast agents (GBCAs) and nephrogenic systemic fibrosis (NSF): “Why did it happen” and “What have we learned”? It reviews the events leading to the discovery of an association between NSF and GBCAs. Various factors are elucid